FMC Corporation and Bayer collaborate to bring Isoflex™ active herbicide technology to European markets
FMC (NYSE: FMC) has announced a strategic partnership with Bayer to commercialize products containing Isoflex™ active herbicide in the European Union and Great Britain. The collaboration targets an estimated 30 million planted hectares of winter cereals market.
Isoflex™ active, a Group 13 herbicide, received registration in Great Britain in 2024, with EU registration anticipated in 2025. The product provides control of resistant grass weeds in cereals and other crops. Under the agreement, both companies will market Isoflex™-based products, with FMC focusing on winter cereals, corn, oilseed rape, and potato markets, while Bayer will handle winter cereals and oilseed rape segments.
The technology has already been successfully launched in multiple countries including Argentina, Australia, Brazil, Chile, China, Pakistan, Uruguay, and India. Product launches are expected in Great Britain later this year and in the EU by 2027, subject to regulatory approval.
FMC (NYSE: FMC) ha annunciato una partnership strategica con Bayer per commercializzare prodotti contenenti Isoflex™ attivo erbicida nell'Unione Europea e in Gran Bretagna. La collaborazione mira a un mercato stimato di 30 milioni di ettari di cereali invernali.
Isoflex™ attivo, un erbicida di Gruppo 13, ha ricevuto la registrazione in Gran Bretagna nel 2024, con la registrazione nell'UE prevista per il 2025. Il prodotto offre il controllo delle erbe infestanti resistenti nei cereali e in altre colture. In base all'accordo, entrambe le aziende commercializzeranno prodotti a base di Isoflex™, con FMC che si concentrerà sui cereali invernali, mais, colza e mercato delle patate, mentre Bayer gestirà i segmenti dei cereali invernali e della colza.
La tecnologia è già stata lanciata con successo in diversi paesi tra cui Argentina, Australia, Brasile, Cile, Cina, Pakistan, Uruguay e India. I lanci di prodotto sono previsti in Gran Bretagna entro la fine di quest'anno e nell'UE entro il 2027, soggetti ad approvazione normativa.
FMC (NYSE: FMC) ha anunciado una asociación estratégica con Bayer para comercializar productos que contengan Isoflex™ herbicida activo en la Unión Europea y Gran Bretaña. La colaboración tiene como objetivo un mercado estimado de 30 millones de hectáreas de cereales de invierno.
Isoflex™ activo, un herbicida del Grupo 13, recibió la autorización en Gran Bretaña en 2024, con la autorización de la UE anticipada para 2025. El producto proporciona control de malezas resistentes en cereales y otros cultivos. Según el acuerdo, ambas empresas comercializarán productos basados en Isoflex™, con FMC enfocándose en cereales de invierno, maíz, colza y mercados de papa, mientras que Bayer manejará los segmentos de cereales de invierno y colza.
La tecnología ya se ha lanzado con éxito en varios países, incluidos Argentina, Australia, Brasil, Chile, China, Pakistán, Uruguay e India. Se espera que los lanzamientos de productos en Gran Bretaña ocurran a finales de este año y en la UE para 2027, sujeto a aprobación regulatoria.
FMC (NYSE: FMC)는 Bayer와 전략적 파트너십을 체결하고 Isoflex™ 활성 제초제를 유럽 연합과 영국에서 상용화할 예정이라고 발표했습니다. 이 협력은 겨울 곡물 시장의 약 3천만 헥타르를 목표로 하고 있습니다.
Isoflex™ 활성은 그룹 13 제초제로, 2024년 영국에서 등록되었으며, 2025년에는 EU 등록이 예상됩니다. 이 제품은 곡물과 기타 작물에서 내성 잡초를 제어하는 데 도움을 줍니다. 계약에 따라 두 회사는 Isoflex™ 기반 제품을 마케팅할 것이며, FMC는 겨울 곡물, 옥수수, 유채 및 감자 시장에 집중하고, Bayer는 겨울 곡물 및 유채 부문을 담당합니다.
이 기술은 이미 아르헨티나, 호주, 브라질, 칠레, 중국, 파키스탄, 우루과이, 인도 등 여러 국가에서 성공적으로 출시되었습니다. 제품 출시는 올해 말 영국에서, 2027년까지 EU에서 예정되어 있으며, 규제 승인을 받아야 합니다.
FMC (NYSE: FMC) a annoncé un partenariat stratégique avec Bayer pour commercialiser des produits contenant Isoflex™ herbicide actif dans l'Union européenne et en Grande-Bretagne. La collaboration vise un marché estimé à 30 millions d'hectares de céréales d'hiver.
Isoflex™ actif, un herbicide de groupe 13, a reçu son enregistrement en Grande-Bretagne en 2024, avec un enregistrement dans l'UE prévu pour 2025. Le produit permet de contrôler les mauvaises herbes résistantes dans les céréales et d'autres cultures. Dans le cadre de l'accord, les deux entreprises commercialiseront des produits à base d'Isoflex™, FMC se concentrant sur les céréales d'hiver, le maïs, le colza et le marché de la pomme de terre, tandis que Bayer s'occupera des segments de céréales d'hiver et de colza.
La technologie a déjà été lancée avec succès dans plusieurs pays, dont l'Argentine, l'Australie, le Brésil, le Chili, la Chine, le Pakistan, l'Uruguay et l'Inde. Les lancements de produits sont attendus en Grande-Bretagne plus tard cette année et dans l'UE d'ici 2027, sous réserve de l'approbation réglementaire.
FMC (NYSE: FMC) hat eine strategische Partnerschaft mit Bayer angekündigt, um Produkte mit Isoflex™ aktivem Herbizid in der Europäischen Union und Großbritannien zu vermarkten. Die Zusammenarbeit zielt auf einen geschätzten Markt von 30 Millionen Hektar Wintergetreide ab.
Isoflex™ aktiv, ein Herbizid der Gruppe 13, erhielt 2024 die Zulassung in Großbritannien, während die EU-Zulassung für 2025 erwartet wird. Das Produkt bietet Kontrolle über resistente Grasunkräuter in Getreide und anderen Kulturen. Im Rahmen der Vereinbarung werden beide Unternehmen Isoflex™-basierte Produkte vermarkten, wobei sich FMC auf Wintergetreide, Mais, Raps und Kartoffelmärkte konzentriert, während Bayer die Segmente Wintergetreide und Raps übernimmt.
Die Technologie wurde bereits erfolgreich in mehreren Ländern wie Argentinien, Australien, Brasilien, Chile, China, Pakistan, Uruguay und Indien eingeführt. Produktlaunches sind für Großbritannien später in diesem Jahr und für die EU bis 2027 geplant, vorbehaltlich der regulatorischen Genehmigung.
- Strategic partnership with Bayer expands market access in EU and GB
- Product already successfully commercialized in 8 major agricultural markets
- Addresses critical market need for resistant weed control
- Large market opportunity with 30 million hectares of winter cereals
- EU market entry delayed until 2027 pending regulatory approval
- Dependent on regulatory decisions for market access
Insights
FMC's partnership with Bayer represents a strategic expansion of its novel Isoflex™ herbicide technology into the European agricultural market. The agreement targets an estimated 30 million hectares of winter cereals in the EU and Great Britain, creating substantial market opportunity for FMC's proprietary Group 13 herbicide.
What makes this deal particularly valuable is that Isoflex™ addresses a critical agricultural challenge: controlling grass weeds that have developed resistance to existing herbicide solutions. As weed resistance continues to threaten crop yields, products offering new modes of action like Isoflex™ command premium positioning in the crop protection market.
The collaboration structure intelligently leverages both companies' strengths. FMC maintains control of its technology while gaining access to Bayer's robust European distribution network, accelerating market penetration. Meanwhile, Bayer enhances its herbicide portfolio with a novel solution without incurring R&D development costs.
FMC's global rollout success in markets like Argentina, Australia, Brazil, and China demonstrates the technology's commercial viability and farmer acceptance. The European expansion comes with a phased approach - Great Britain launches later this year followed by EU rollout in 2027, creating a multi-year growth opportunity as regulatory approvals progress.
The agreement adds an important recurring revenue stream to FMC's portfolio in the valuable European market, though investors should note the extended timeline for full EU commercialization pending regulatory decisions. The absence of financial terms prevents precise revenue impact assessment, but the strategic value in expanding FMC's global footprint for this proprietary technology is clearly positive.
The regulatory pathway outlined for Isoflex™ herbicide in Europe reveals both progress and remaining hurdles. The Great Britain registration achieved in 2024 represents a significant milestone, enabling near-term commercialization in that market. However, the EU regulatory process appears less advanced, with approval "anticipated" in 2025 but product launches not expected until 2027.
This regulatory timeline disparity between Great Britain and the EU reflects the post-Brexit regulatory divergence, with the UK implementing a more streamlined approval process while the EU maintains its comprehensive, multi-stage assessment framework through authorities like EFSA and member state evaluations.
The Herbicide Resistance Action Committee (HRAC) classification of Isoflex™ as a Group 13 herbicide is particularly significant for regulatory positioning. Novel modes of action facing less regulatory scrutiny regarding resistance development concerns that plague older chemistries. This differentiation should facilitate approval processes, though the standard European 2-3 year timeline between active ingredient approval and formulated product authorizations explains the 2025-2027 gap mentioned.
The mention of "products containing Isoflex™ active" suggests multiple formulations tailored for different crops and geographies - a sophisticated regulatory approach requiring substantial dossier preparation but maximizing market potential. Bayer's involvement in registration submissions for mixture products adds regulatory resources and expertise that should enhance approval probability.
The established registration precedent in eight other countries provides regulatory authorities with real-world safety and efficacy data, typically strengthening new market applications. Overall, while regulatory uncertainty exists, the defined pathway and Bayer partnership significantly de-risk the European approval process for FMC's technology.
Isoflex™ active, classified by the Herbicide Resistance Action Committee (HRAC) as a Group 13 herbicide, received registration in
"This agreement will allow FMC to expand market access in the European Union and
Under the terms of the agreement, both companies will bring products containing Isoflex™ active to the winter cereals and oilseed rape markets in the European Union and
"In the face of climate change and pressure on food systems, farmers need effective tools to control weeds," said Frank Terhorst, executive vice president of strategy and sustainability at Bayer's Crop Science Division. "Herbicides like Isoflex™ active play an important part in that, to eventually contribute to food security. We are happy to make use of synergies with FMC to achieve this goal."
The European launches will build on FMC's successful global rollout of products powered by Isoflex™ active, which have already been registered and commercialized in
To learn more about Isoflex™ active, please visit FMC.com/isoflexactive.
About FMC
FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC's innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers and crop advisers to address their toughest challenges economically while protecting the environment. FMC is committed to discovering new herbicide, insecticide and fungicide active ingredients, product formulations and pioneering technologies that are consistently better for the planet. Visit fmc.com to learn more and follow us on LinkedIn®.
About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, "Health for all, Hunger for none," the company's products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2024, the Group employed around 93,000 people and had sales of
FMC and Isoflex are trademarks of FMC Corporation and/or an affiliate. Always read and follow all label directions, restrictions and precautions for use. Products listed here may not be registered for sale or use in all states, countries or jurisdictions.
Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995: FMC and its representatives may from time to time make written or oral statements that are "forward-looking" and provide other than historical information, including statements contained in this press release, in FMC's other filings with the SEC, and in presentations, reports or letters to FMC stockholders.
In some cases, FMC has identified these forward-looking statements by such words or phrases as "outlook", "will likely result," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "predicts," "forecasts," "estimates," "projects," "potential," "intends" or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the risk factors included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2024 (the "2024 Form 10-K"), the section captioned "Forward-Looking Information" in Part II of the 2024 Form 10-K and to similar risk factors and cautionary statements in all other reports and forms filed with the Securities and Exchange Commission ("SEC"). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Forward-looking statements are qualified in their entirety by the above cautionary statement.
We specifically decline to undertake any obligation, and specifically disclaims any duty, to publicly update or revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except as may be required by law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/fmc-corporation-and-bayer-collaborate-to-bring-isoflex-active-herbicide-technology-to-european-markets-302416143.html
SOURCE FMC Corporation
FAQ
When will FMC's Isoflex herbicide launch in the European Union?
What markets will FMC's Isoflex herbicide target in Europe?
How many hectares of winter cereals market will FMC's Isoflex potentially reach in Europe?
In which countries is FMC's Isoflex herbicide already available?
What type of herbicide is FMC's Isoflex classified as?
